Skip to search formSkip to main contentSkip to account menu

SAR103168

Known as: Multikinase Inhibitor SAR103168 
A multikinase inhibitor with potential antineoplastic activity. Upon intravenous infusion, multikinase inhibitor SAR103168 may, through the… 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

PyridinesPyrimidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Phase I trial of SAR103168, a novel multi-kinase inhibitor, in patients with refractory/relapsed acute leukemia or high-risk myelodysplastic syndrome
Abstract There is no effective treatment for relapsed/refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS… 
2014
2014
Frühes Monitoring der antivaskulären Effekte von Multikinase-Inhibitoren (MKI) bei Patienten mit metastasiertem Nierenzellkarzinom (mNZK) mittels Perfusions-CT: Initiale Ergebnisse einer Pilotstudie
2013
2013
SAR103168: a tyrosine kinase inhibitor with therapeutic potential in myeloid leukemias
Abstract SAR103168, a tyrosine kinase inhibitor of the pyrido [2,3-d] pyridimidine subclass, inhibited the kinase activities of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)